Research Article
Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count)
Table 1
General characteristics and univariate analysis.
| Variable | Total | Malignant pleural effusion | Tubercular pleural effusion | P value |
| Age | 65 (19–87) | 69 (35–87) | 56 (19–87) | 0.23 | Pleural ADA (U/L) | 10.6 (5–54) | 9 (5–42) | 42 (5–54) | 0.001 | Serum LDH (IU/L) | 512 (322–2992) | 525 (322–2992) | 494 (336–947) | 0.08 | Pleural fluid lymphocyte count (%) | 0.7 (0.1–1.0) | 0.61 (0.10–1.0) | 0.86 (0.60–1.0) | 0.007 | Cancer ratio | 51.5 (7–173) | 74 (15–173) | 13 (7–67) | 0.008 | Serum LDH/pleural fluid lymphocyte count | 765.5 (336–7771) | 1015 (498–7771) | 593 (336–1230) | 0.006 | Cancer ratio/pleural fluid lymphocyte count | 87.2 (7.5–1295.2) | 127 (29–1295) | 16 (8–67) | 0.002 |
|
|
Data presented in median (range).
|